How technology in health is reshaping medical devices and care delivery
Technology in health is becoming part of the device itself
Technology in health now means more than placing digital tools alongside traditional care. In medical devices, sensors, software, connectivity, analytics, and workflow integration are increasingly part of how equipment performs its intended clinical function. This is shifting the market from standalone machines to connected systems that can capture data, support decisions, monitor patients remotely, and be updated over time. The shift can improve access, efficiency, and earlier detection, but it also raises harder questions about evidence, cybersecurity, interoperability, usability, and postmarket oversight.
For medical device manufacturers, hospitals, clinicians, and buyers, the main issue is no longer whether healthcare will become more digital. It already has. The more useful question is how to adopt digital health tools without introducing unsafe automation, unusable data streams, or hidden operational risk.
This article reviews the main areas where technology is changing health care delivery and medical equipment, using public information from organizations such as the WHO, FDA, HHS, ONC, and European Commission. For more coverage of connected care, diagnostics, and device regulation, visit the healthcare technology section.
What the term covers in medical device settings
In everyday search behavior, people often use technology in health to mean digital health, health IT, medical device innovation, artificial intelligence, telehealth, wearables, and connected hospital systems. In a medical equipment context, the phrase is most useful when it is narrowed to technologies that directly affect diagnosis, monitoring, treatment, clinical operations, or patient access.
The WHO’s Global strategy on digital health 2020–2025, published on August 18, 2021, presents digital health as a system-level issue rather than a collection of isolated apps. It emphasizes that digital initiatives need organizational, human, financial, and technical resources if they are to support health outcomes instead of fragmenting services.
That distinction matters for device readers. A connected blood pressure monitor, AI imaging tool, digital pathology system, or remote cardiac monitor is not only a product. It also depends on data quality, clinical workflow, patient behavior, network reliability, cybersecurity management, and often regulatory review. A technically strong device can still fail in practice if it creates alert fatigue, does not integrate with records, or lacks a clear process for software updates.
Five technologies changing care delivery
AI-enabled medical devices and clinical decision support
Artificial intelligence is one of the most visible examples of technology in health. The FDA maintains a public AI-enabled medical device list to identify devices authorized for marketing in the United States. The agency notes that the list is not fully comprehensive because it is largely based on AI-related terms in public summary documents, but it remains a useful indicator of where regulated device innovation is heading.
Most authorized AI-enabled devices have historically appeared in imaging-related areas, especially radiology, because imaging produces structured digital data and measurable outputs that suit algorithmic analysis. AI is also expanding into cardiology, pathology, diabetes tools, triage, signal analysis, and hospital workflow support.
The practical value of AI in devices is not that software replaces clinicians. In most current clinical settings, the stronger use cases are prioritization, detection support, segmentation, measurement, quality control, and risk flagging. The limitation is that performance can vary across patient groups, sites, acquisition protocols, and real-world workflows. Buyers should therefore ask for validation data that reflects their intended population and use environment.
Remote patient monitoring and virtual care
Remote patient monitoring moves device-generated data from the clinic into homes, ambulatory settings, and long-term care environments. Examples include connected glucose monitors, blood pressure cuffs, pulse oximeters, weight scales, cardiac monitors, and wearable sensors. These tools can help clinicians follow chronic conditions between visits, but they can also create large volumes of data that require triage rules and staffing models.
Public HHS telehealth trend data show that 25% of Medicare fee-for-service users had a telehealth service in 2024, unchanged from 2023. That figure does not measure all remote monitoring, but it does show that virtual care has remained part of mainstream care access after the early pandemic surge. AMA survey findings from 2022 also showed broad physician adoption of virtual visits, while remote monitoring adoption was lower, reflecting the workflow burden of continuous or recurring device data.
Interoperability and health data exchange
Interoperability determines whether device data become clinically useful or stay trapped in separate dashboards. In the United States, ONC’s HTI-1 final rule updates the ONC Health IT Certification Program and adopts USCDI Version 3 as the baseline standard from January 1, 2026. The rule also introduces algorithm transparency requirements for predictive tools that are part of certified health IT.
For hospitals, this means technology decisions should not stop at device accuracy or hardware cost. Procurement teams need to ask whether a device can exchange data with the electronic health record, whether the data elements map cleanly to existing workflows, and whether clinicians can understand how algorithmic outputs should be interpreted.
Cybersecurity and connected medical equipment
Connectivity improves care coordination, but it also expands the attack surface. The FDA has repeatedly stated that medical devices connected to the internet, hospital networks, or other devices can introduce cybersecurity risks that may affect safety and effectiveness. Section 524B of the Federal Food, Drug, and Cosmetic Act, created through the Consolidated Appropriations Act, 2023, took effect on March 29, 2023, and added explicit cybersecurity expectations for certain cyber devices.
The FDA issued updated final cybersecurity guidance on June 27, 2025, superseding its September 27, 2023 final guidance. For manufacturers, cybersecurity is now a lifecycle responsibility involving secure design, documentation, vulnerability handling, and postmarket monitoring. For health delivery organizations, the lesson is equally practical: no connected device should be evaluated only as clinical equipment. It is also a networked asset that needs inventory control, patch planning, incident response, and shared responsibility between vendors and providers.
Digitally derived measures and automation
Clinical investigations and routine care are increasingly using digitally derived measures, such as activity, sleep, heart rhythm, gait, or physiological trends captured by sensors. These measures can reduce dependence on episodic clinic visits and may support decentralized trials or long-term disease monitoring.
However, a digital measure is not automatically meaningful because it is continuous. The measurement must be fit for purpose. Teams need to understand what the sensor measures, whether the algorithm has been validated, how missing data are handled, and whether the output changes a clinical decision. A large dataset without clinical context can create noise rather than insight.
Source comparison for practical decision-making
Because technology in health is shaped by several types of authorities, it helps to separate global strategy, regulation, reimbursement, and technical adoption. The table below summarizes the most relevant public signals for medical device and healthcare technology readers. See also: clinical equipment.
| Area | Public source signal | Practical takeaway |
|---|---|---|
| Digital health strategy | WHO Global strategy on digital health 2020–2025 | Digital tools should be planned as health system infrastructure, not isolated pilots. |
| AI-enabled devices | FDA AI-enabled medical device list, updated periodically | AI adoption is moving through regulated device pathways, but public summaries do not always reveal all validation details. |
| Virtual care | HHS telehealth trend data for Medicare fee-for-service users | Telehealth remains a meaningful access channel, while remote monitoring needs stronger workflow design. |
| Interoperability | ONC HTI-1 final rule and USCDI Version 3 baseline | Device data value depends on exchange standards, record integration, and algorithm transparency. |
| Cybersecurity | FDA cybersecurity guidance and FD&C Act section 524B | Connected devices require secure design, documentation, vulnerability management, and postmarket planning. |
| AI governance in Europe | EU Artificial Intelligence Act, in force from August 1, 2024 | AI-based medical software can fall into high-risk regulatory expectations, including risk management, data quality, transparency, and human oversight. |
Why adoption is harder than buying new equipment
The business case for digital medical technology often focuses on speed, efficiency, earlier detection, and improved access. Those benefits are real possibilities, but they are not automatic. Implementation usually fails for operational reasons before it fails for technological reasons.
First, clinical workflow determines whether people use the tool. A device that sends too many alerts, requires duplicate documentation, or pushes clinicians into a separate portal may increase workload. Remote monitoring programs are especially sensitive to this issue because the data arrive outside the traditional visit structure.
Second, data governance determines whether results can be trusted. AI tools and digitally derived measures need clear documentation on training data, validation data, intended users, intended patient populations, and known limitations. If a model is trained on data that do not resemble a hospital’s patient mix, local monitoring becomes essential.
Third, maintenance becomes continuous. Traditional equipment may be serviced at defined intervals, while software-enabled equipment may require security patches, model updates, operating system compatibility checks, cloud service reviews, and change control. FDA guidance on predetermined change control plans for AI-enabled device software functions, issued as final guidance in August 2025, reflects this broader shift toward planned lifecycle management.
Fourth, equity and access must be considered from the start. Virtual care and home monitoring can help patients who live far from specialty care, but they can also disadvantage people with limited broadband, low digital literacy, language barriers, or unstable housing. A health technology strategy should include lower-tech alternatives, training, accessibility, and clear escalation routes.
What hospitals and device teams should evaluate before adoption
For readers comparing connected medical equipment or software-enabled devices, a structured assessment is more useful than a generic innovation checklist. The following questions help separate clinically useful technology from tools that may create avoidable risk.
- Intended use: What decision does the technology support, and who is responsible for acting on its output?
- Evidence: Does validation reflect the target population, clinical setting, device inputs, and workflow?
- Interoperability: Can the data move into existing health IT systems without manual workarounds?
- Usability: How will alerts, dashboards, and documentation affect clinicians during real shifts?
- Cybersecurity: Is there an SBOM, vulnerability disclosure process, patch schedule, and incident response plan?
- Lifecycle management: What happens when the software, algorithm, sensor, or cloud component changes?
- Equity: Which patients may be excluded because of connectivity, language, disability, or cost barriers?
- Financial fit: Are reimbursement, staffing, maintenance, training, and support costs included in the adoption model?
These questions are especially important for AI-enabled and sensor-based devices because their value depends on both technical performance and clinical integration. A device can be accurate in a study and still underperform if the real-world setting is different, the data are incomplete, or clinicians do not trust the output.
Where technology in health is likely to create the most value
The strongest near-term value is likely to appear where technology solves a specific bottleneck rather than adding a broad digital layer. Examples include AI-assisted image prioritization, automated measurements that reduce repetitive work, remote monitoring for defined chronic disease pathways, connected diagnostics in point-of-care settings, and interoperable device data that reduce manual transcription.
Medical device companies that succeed in this environment will treat software, data, cybersecurity, usability, and evidence generation as core product requirements. Health systems that succeed will avoid adopting technology for novelty alone. They will define the clinical problem first, select tools that fit the workflow, measure outcomes after deployment, and stop or redesign programs that do not improve care.
The next stage of healthcare technology will not be judged only by how advanced the device appears. It will be judged by whether it safely changes decisions, reduces burden, protects patients, and works across the messy conditions of real care delivery.
Frequently asked questions
What does technology in health mean?
It refers to the use of digital tools, connected devices, software, data systems, automation, and analytics to support prevention, diagnosis, treatment, monitoring, and health system operations. In medical devices, it often includes AI-enabled software, sensors, remote monitoring, interoperability, and cybersecurity controls.
How is AI used in medical devices?
AI is commonly used to detect patterns, prioritize cases, segment images, measure structures, analyze physiological signals, or support risk assessment. Most current tools are designed to assist clinicians rather than operate independently. Their safe use depends on intended use, validation, transparency, and monitoring after deployment.
Why is interoperability important for healthcare technology?
Interoperability allows device and software data to move into clinical records and workflows. Without it, clinicians may need to check separate portals, copy values manually, or make decisions from incomplete information. Standards and certification programs help make data exchange more consistent.
What is the main risk of connected medical devices?
The main risk is not only technical failure. Connected devices can introduce cybersecurity vulnerabilities, workflow burden, data overload, and unclear responsibility for action. These risks can affect patient safety if they are not addressed through design, training, maintenance, and shared governance.
Will digital health replace in-person care?
Digital health is more likely to complement in-person care than replace it. Telehealth, remote monitoring, and AI-assisted tools can extend access and support earlier intervention, but many conditions still require physical examination, procedures, imaging, laboratory testing, or direct clinician interaction.
